7.0853
-0.2147 (-2.94%)
-0.2147 (-2.94%)
Upgrade to Real-Time
Regular Market
Low
3.55
High
17.75
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cyclo Therapeutics Inc | CYTH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.2147 | -2.94% | 7.0853 | 09:58:26 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.14 | 7.05 | 7.25 | 7.30 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 7.05 | 7.25 | 0.20 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 29 | 3,696 | $ 7.14 | $ 26,394 | 248,376 | 3.55 - 17.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:58:26 | 199 | $ 7.0853 | USD |
Cyclo Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 45.06M | 6.36M | 5.73M | $ 903.38k | $ - | -6.60 | -1.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 32.05k | - |
Cyclo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYTH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.96 | 8.44 | 6.9853 | 7.75 | 96,703 | -0.8747 | -10.99% |
| 1 Month | 7.30 | 9.38 | 6.25 | 7.87 | 204,040 | -0.2147 | -2.94% |
| 3 Months | 10.82 | 14.88 | 6.25 | 9.39 | 455,525 | -3.73 | -34.52% |
| 6 Months | 4.19 | 17.75 | 3.55 | 7.70 | 1,112,674 | 2.90 | 69.1% |
| 1 Year | 4.19 | 17.75 | 3.55 | 7.70 | 1,112,674 | 2.90 | 69.1% |
| 3 Years | 4.19 | 17.75 | 3.55 | 7.70 | 1,112,674 | 2.90 | 69.1% |
| 5 Years | 4.19 | 17.75 | 3.55 | 7.70 | 1,112,674 | 2.90 | 69.1% |
Cyclo Therapeutics Description
| Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex. |
